文献速递乳房整形与再造

化疗与放疗对乳房再造中脱细胞真皮基质炎症反应、新生血管化和包膜形成的影响:BREASTrial活检标本分析

Impact of Chemotherapy and Radiation Therapy on Inflammatory Response, Neovascularization, and Capsule Formation of Acellular Dermal Matrix in Breast Reconstruction: Analysis of the BREASTrial Biopsy Specimens.
PubMed 文献 · Plast Reconstr Surg · 2022-01-01

BREASTrial为单中心、盲法、前瞻性随机对照试验,比较AlloDerm与DermaMatrix在组织扩张器乳房再造中的效果。对109例患者(170侧乳房)的脱细胞真皮基质活检标本分析显示,无辅助治疗时两种基质在炎症、新生血管化或包膜厚度上无显著差异;辅助治疗使两者炎症和新生血管化均显著降低,且化疗联合放疗时DermaMatrix组炎症降低最明显(p<0.039)。

要点

  • 无辅助治疗时,AlloDerm与DermaMatrix在炎症、新生血管化及包膜厚度上无显著差异。
  • 辅助治疗使两种脱细胞真皮基质的炎症和新生血管化均显著降低。
  • 化疗联合放疗时,DermaMatrix组炎症降低最明显(p<0.039)。

核心结论

  • 辅助治疗影响两种脱细胞真皮基质的炎症反应、新生血管化和包膜形成。
  • 辅助治疗对两种脱细胞真皮基质在乳房再造中的炎症反应具有保护作用。
  • 在化疗和放疗情况下,DermaMatrix产生的炎症降低最明显。

研究设计与样本

  • BREASTrial为单中心、盲法、前瞻性随机对照试验,比较AlloDerm与DermaMatrix在组织扩张器乳房再造中的应用。
  • 在扩张器置换时取穿刺活检标本,由盲法病理学家分析。
  • 组织学标本来自109例患者(170侧乳房)。

主要发现

  • 无辅助治疗时,AlloDerm与DermaMatrix在炎症、新生血管化或包膜厚度方面无显著差异。
  • 两种脱细胞真皮基质在辅助治疗后炎症和新生血管化均显著降低。
  • 化疗联合放疗时,DermaMatrix再造组的炎症降低最明显(p<0.039)。

关键数值与推荐

  • 炎症反应通过成纤维细胞、巨细胞和淋巴细胞数量量化。
  • 新生血管化和包膜形成分别通过新生毛细血管数量及包膜存在与厚度量化。
  • 证据等级:治疗性,II级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Breast Reconstruction Evaluation of Acellular Dermal Matrix as a Sling Trial is a single-center, blinded, prospective, randomized, controlled trial established to compare outcomes using two popular types of acellular dermal matrices, AlloDerm and DermaMatrix, in tissue expander breast reconstruction. This study used the acellular dermal matrix biopsy specimens from the trial to evaluate how adjuvant therapy influences inflammation, neovascularization, and capsule formation of the acellular dermal matrix. METHODS: Punch biopsy specimens were taken at the time of expander exchange and were analyzed by a blinded pathologist. The inflammatory response was quantified by the number of fibroblasts, giant cells, and lymphocytes. Neovascularization and capsule formation were similarly quantified by the number of new capillaries and capsule presence and thickness, respectively. RESULTS: Histology specimens were collected from 109 patients (170 breasts). In the absence of adjuvant therapy, there was no significant difference between AlloDerm and DermaMatrix in terms of inflammation, neovascularization, or capsule thickness. Both acellular dermal matrices showed a significant decrease in inflammation and neovascularization with adjuvant therapy. When chemotherapy and radiation therapy were used, the decrease in inflammation was greatest for the group reconstructed with DermaMatrix (p < 0.039). CONCLUSIONS: Adjuvant therapy influences the inflammatory response, neovascularization, and capsule formation in both acellular dermal matrices. Adjuvant therapy has a protective effect on the inflammatory response toward both acellular dermal matrices in breast reconstruction. In the setting of chemotherapy and radiation therapy, DermaMatrix produced the greatest reduction in inflammation. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Mendenhall SD, Graham EM, Anderson LA, et al. Impact of Chemotherapy and Radiation Therapy on Inflammatory Response, Neovascularization, and Capsule Formation of Acellular Dermal Matrix in Breast Reconstruction: Analysis of the BREASTrial Biopsy Specimens. Plast Reconstr Surg. 2022. PMID: 35196668. doi:10.1097/PRS.0000000000008824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。